- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/52 - Cytokines; Lymphokines; Interférons
Détention brevets de la classe C07K 14/52
Brevets de cette classe: 1570
Historique des publications depuis 10 ans
|
76
|
87
|
112
|
124
|
130
|
142
|
144
|
115
|
115
|
28
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 18943 |
24 |
| Genentech, Inc. | 3742 |
19 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
19 |
| Yale University | 2204 |
18 |
| The General Hospital Corporation | 4517 |
15 |
| Vib VZW | 799 |
15 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
13 |
| The Trustees of the University of Pennsylvania | 4122 |
13 |
| Universiteit Gent | 1276 |
13 |
| Institute for Research in Biomedicine (IRB) | 41 |
12 |
| Lipoxen Technologies Limited | 65 |
12 |
| Arla Foods amba | 510 |
11 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
11 |
| Ith Immune Therapy Holdings | 16 |
11 |
| Amgen Inc. | 3779 |
9 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
9 |
| Washington University | 1473 |
9 |
| IBC Pharmaceuticals, Inc. | 99 |
8 |
| Nant Holdings IP, LLC | 659 |
8 |
| Osaka University | 3143 |
8 |
| Autres propriétaires | 1313 |